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Abstract: Depression is a major problem in youth mental health. Current treatment is on average
effective, but adolescents are hesitant to seek help. Blended treatment could lower the barriers
to seeking treatment. Evidence on effectiveness is, however, scarce. The present pragmatic quasi-
experimental controlled trial aimed to compare the outcomes of blended cognitive behavioral therapy
(CBT) to face-to-face CBT and treatment as usual. A total of 129 adolescents with clinical depres-
sion (82.2% female), aged 13–22 (M = 16.60, SD = 2.03) received blended CBT, face-to-face CBT
or treatment as usual. Clinical diagnosis, depressive symptoms, and secondary outcomes were
assessed at baseline, post-intervention, and six-months follow-up. Participants receiving blended
CBT were, compared to participants receiving face-to-face CBT and treatment as usual, evenly likely
to be in remission from their depressive disorder at post-intervention and at six-month follow-up.
Depressive symptoms decreased significantly over time in all three conditions, and changes were
not significantly different between conditions. Other secondary outcomes (suicide risk, internalizing
and externalizing symptoms, severity of depression, and global functioning) did not differ between
treatment conditions at post-intervention and six-month follow-up. Since there was no evidence
for favorable outcomes for face-to-face therapies above blended CBT, blended CBT may also be an
effective treatment format in clinical practice.
Keywords: adolescents; depression; treatment; blended; CBT
1. Background
Depression has been identified as one of the most prevalent mental health disorders
in adolescents and for boys and girls aged 10 to 19 years and is the most important cause
of burden and disability [1]. Depressive disorders show a high comorbidity with other
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mental health disorders [2], have a high risk of recurrence and chronicity [3,4], and are
a major risk for suicidal behavior and completed suicide [5]. Furthermore, depression
during adolescence is negatively related to social and family functioning [6,7], associated
with poor academic and occupational performance [7,8], and related to poor physical and
mental health in later life [9,10].
Several meta-analyses have shown that Cognitive Behavioral Therapy (CBT) and In-
terpersonal Therapy (IPT) are both effective interventions for adolescents with a depressive
disorder [11–14]. There is ample research showing positive effects and both interventions
are qualified as first choice treatment for adolescents suffering from depression in several
national and international guidelines [15,16]. However, it is also known that effect sizes
are on average small to moderate and not all adolescents show improvement and are free
of symptoms after receiving treatment [14,17,18]. Importantly, adolescents themselves
mentioned lack of time, high costs, lack of available transport, perceived social stigma,
and limited treatment resources as the most important reasons for not seeking help [19,20].
Therefore, computerized interventions, such as internet-based CBT, are often mentioned as
alternative for face-to-face treatment, because they contribute to increasing dissemination
of mental health care by being scalable and can be made widely available [21]. It has low
barriers for participation considering that it is free of costs, is flexible, retains anonymity
and therefore carries no stigmatization [22,23], but more importantly, it has proven to be
effective in reducing depressive symptoms in adolescents [20]. Nevertheless, unguided
computerized treatment for depression may not the best strategy for adolescents, since
drop-out, increasing symptom severity and suicidal ideation, all common in youth with a
depressive disorder, are hard to detect and tackle in unguided computerized treatment in
comparison to face-to-face treatment [22]. To prevent drop-out, improve results of online
treatment, and monitor possible adverse events, adolescents should be able to connect
with mental health professionals [24]. Taken together, merging face-to-face treatment
and computerized treatment into an integrated blended treatment would be the optimal
combination of elements from both forms of treatment [25–28].
Blended treatment can be defined as an integrated treatment, containing face-to-
face sessions with a mental health professional combined with computerized therapy
which patients follow independently [26]. The computerized part of the treatment is
delivered through an online, secured, platform, which can be accessed by pc or smart
phone. Adolescents independently work through several modules, containing psycho-
education and exercises, and therapists deliver feedback and guidance on the platform [25].
The computerized part is combined with face-to-face sessions. According to therapists
and patients, the face-to-face sessions are preferably used for getting to know one another,
establishing the therapeutic relationship, and preparing to use the computerized part
of the program [26,29]. The face-to-face sessions between adolescents and therapists are
synchronized in communication, in which blended treatment differs from guided treatment,
where contact with therapist is often online (e.g., via chat) or asynchronous. This means that
blended treatment contains the benefits of both face-to-face treatment and computerized
treatment; it serves the purpose of being flexible in location and intensity and meets the
requirements of personal contact, adaptability in content, and safety in monitoring changes
in severity, and according to therapists, it increases the engagement of adolescents in the
treatment and enhances self-management [26,30].
Although blended treatment has the potential to be used on a large scale in youth
mental health care, the evidence of effectiveness is scarce. To our knowledge, only a
few studies have examined the effectiveness of blended treatment for adolescents with
a depressive disorder. Two randomized controlled trials compared the effects of face-to-
face CBT, computerized CBT, and face-to-face CBT and computerized CBT in conjunction
(i.e., blended treatment) to a control condition without treatment among students with mild
to moderate depressive symptoms [31,32]. These studies revealed that both blended CBT
and face-to-face CBT were effective in reducing depressive symptoms and participants in
both conditions showed a larger decrease in depressive symptoms compared to participants
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in the computerized CBT or control condition. In a third randomized controlled trial,
blended CBT was compared to treatment as usual in treating adolescents with depressive
disorders [33]. Adolescents in both treatment conditions showed significant reductions in
depressive symptoms, with no significant differences between conditions. Two randomized
controlled trials by Topooco et al. [34,35] showed that an online program including eight
weekly chat-sessions resulted in significantly lower depressive symptoms when compared
to control conditions comprising active monitoring or non-specific counseling. Although
these findings provide a positive perspective on blended CBT, it is unknown whether not
seeing patients face-to-face regularly increases the risk of adverse events including suicide
risk [36], and whether the presented effects can be translated to adolescents treated in
routine care.
The purpose of the present study was to evaluate the outcomes of blended CBT; the
design was described in a study protocol [37], and the study compares the outcomes of
Doepressie Blended with Doepressie face-to-face (CBT) and with treatment as usual (TAU).
Patients in the latter two conditions had already participated in a previous randomized
controlled trial (RCT) comparing face-to-face CBT with TAU [38,39]. The main aim was to
evaluate and compare the remission rate of depressive disorders between blended CBT
and face-to-face CBT and between blended CBT and treatment as usual in adolescents with
clinical depression within routine care. Based on previous research in recent years, we
hypothesized that the remission rate for depressive disorders was not different from face-to-
face CBT, but was higher compared to treatment as usual. The second aim was to explore the
differences in outcomes between blended CBT and face-to-face CBT and between blended
CBT and treatment as usual on secondary outcomes: depressive symptoms, suicide risk,
internalizing and externalizing symptoms, severity of depression, and global functioning.
2. Methods
2.1. Ethics
Both studies were approved by the Medical Research Ethics Committee METC Utrecht,
The Netherlands (protocol NL61804.041.17 approved on 10 October 2017 and protocol
NL34064.041.10 approved on 14 June 2011) and were registered in the Dutch Trial Register
(NTR; Trial IDs: NTR6759 registered on 16 October 2017 and NTR2676 registered on
3 January 2011). All participants, and if under the age of 16 years also their parents,
provided written informed consent. Results are described according to the CONSORT 2010
statement [40,41] and SPIRIT guidelines [42].
2.2. Design and Procedure
A pragmatic quasi-experimental controlled design was used. Data, collected between
November 2017 and December 2019, from participants receiving blended CBT [37] was
compared to data, collected between December 2011 and June 2014, from participants
receiving face-to-face CBT or TAU (in a previously conducted RCT) [38,39]. A detailed
description of the study design can be found in the published study protocol [37].
Adolescents with a depressive disorder who were referred for treatment in mental
health care were informed about the study together with their parents, and they were
asked to participate. If the adolescent was 16 years or older, parents would only be
approached with the adolescent’s permission. Inclusion criteria were (1) having a clinical
diagnosis of a depressive disorder (Major Depressive Disorder (MDD) or Dysthymic
disorder), (2) aged 12–21 years, and (3) referred to one of the participating mental health
institutions. Exclusion criteria were (1) acute risk of suicide, (2) drug abuse disorder
(as primary diagnosis), (3) pervasive developmental disorder (as primary diagnosis),
(4) bipolar disorder (as primary diagnosis), (5) day care or admission to the clinical setting,
and (6) insufficient knowledge of the Dutch language. Written informed consent was
obtained. In both studies, treatment was provided during 15 weeks and could be prolonged
to 20 weeks when intermitted by holidays or illness. Assessments were conducted at
baseline (T0), during the intervention after five weeks (T1), during the intervention after
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ten weeks (T2), at post-intervention (T3), and at six months (T4) follow-up. Assessments
T0, T3, and T4 are reported in this article. The flow of participants through each phase of
the study is shown in Figure 1.
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2.3. Sample Size
Based on previous research, the within-subject effect sizes of both blended and face-
to-face CBT were estimated to be moderate, i.e., blended CBT d = 0.76 [43] and face-to-face
CBT d = 0.53 [14]. To detect a difference in depression diagnoses between the conditions
(assuming alpha of 0.05 with a power (1−β) of 0.80, and dropout of 20%), 70 adolescents
per condition were required.
2.4. Participants
A total of 129 patients (82.2% female) participated in the study and received either
blended CBT (n = 41), face-to-face CBT (n = 44), or treatment as usual (n = 44). The
adolescents were aged 13–22 years (M = 16.60, SD = 2.03) when they started treatment.
Two participants were 21 when they gave informed consent and turned 22 before treatment
started; they remained included. Educational levels were 2.3% lower educational level,
38.4% moderate educational level, and 58.5% higher educational level. Most participants
were of Dutch origin (96.4%).
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2.5. Treatment Allocation
Adolescents participating in the first study were randomly assigned to either face-
to-face CBT or treatment as usual [39]. Adolescents participating in the second study all
received blended CBT.
2.6. Interventions
The TAU condition consisted of a range of different treatments. In this study, mental
health institutions offered Interpersonal Therapy (IPT), family therapy, parent counsel-
ing, anti-depressant medication, mindfulness training, acceptance commitment therapy
(ACT), short-term psychodynamic therapy, (nondirective) counseling, creative therapy,
and running therapy. For the purpose of this study, CBT was not allowed within the TAU
condition. More detailed information is described by Stikkelbroek and colleagues [39].
For the face-to-face CBT condition, the Dutch protocolized CBT program “Doepressie”
was used [44], which is based on the evidence-based treatment program Coping with
Depression course for Adolescents (CWD-A) [45]. The program consists of 15 weekly
sessions of 45 min each and contains the following components: psycho-education, setting
realistic goals, self-monitoring, activation, improvement of social and communication
skills, relaxation skills, cognitive restructuring, role play, problem solving skills and relapse
prevention. Exercises during the session and homework are used to generalize new skills
into daily practice.
For the blended CBT intervention, the program Doepressie was adapted into a blended
version [46] with an interactive online environment including four modules, covering the
same components mentioned above. The online content of the program was combined
with a flexible number of face-to-face sessions with a therapist (with a minimum of five
and maximum of 15 sessions). Duration of the face-to-face sessions was equal to the face-
to-face condition, namely 45 min each. Throughout the treatment phase, adolescents and
therapist could communicate by means of a chat functionality within the program, email
or phone. Parents received, comparable to the face-to-face Doepressie, two face-to-face
sessions consisting of psycho-education, information about CBT and suggestions on how
to contribute to the treatment.
2.7. Therapists
Treatment was provided by 60 therapists (91.7% female; 98.1% of Dutch origin) across
16 sites. Therapists were aged 24–63 years (M = 42.38, SD = 10.89) and had 2–40 years
(M = 13.54, SD = 9.04) of working experience. Most therapists (95.0%) were licensed
psychologists with one or more clinical registrations. Two therapists were in training to
become cognitive therapists and one therapist was a psychiatric nurse trained as a cognitive
therapist. They each treated between one and six participating adolescents. Therapists in
the face-to-face CBT and blended CBT condition received a two-day training in delivering
the protocolized treatment by a registered clinical psychologist. Therapists in the treatment
as usual condition received instruction not to use CBT. Age and level of experience of
therapists were evenly distributed across the treatment conditions.
2.8. Measures
2.8.1. Primary Outcome
The presence of the diagnosis of depression was measured by the Kiddie-Schedule for
Affective Disorders and Schizophrenia, present and lifetime version (K-SADS-PL) [47,48],
which was conducted by a trained research assistant. This semi-structured diagnostic
interview assesses present and life-time diagnoses and their severity and takes the view
of adolescents and parents into account. Test-retest reliability is excellent for present and
lifetime diagnoses of major depression and interrater agreement is high (93–100%) [47].
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2.8.2. Secondary Outcomes
Depressive symptoms were measured using the Dutch version of the self-report mea-
sure Child Depression Inventory-2 (CDI-2) [49,50]. The questionnaire contains 28 items,
each consisting of three statements rated from 0 to 2.
Suicide risk was assessed with the self-report questionnaire Suicide Risk Taxation
(SRT), consisting of six items rated on a three-point scale. The questionnaire is based on the
Suicide Ideation Questionnaire-Jr [51] and on the Suicide Severity Rating Scale [52]. The
questionnaire assesses frequency of suicidal thoughts, wishes, plans and actions over the
past two weeks.
Internalizing and externalizing symptoms were measured using the Youth Self Report
scale (YSR) [53,54] rated by adolescents. The questionnaire assesses a wide range of symp-
toms with 69 items on a three-point scale, of which 31 items are used for the internalizing
symptoms subscale and 32 for the externalizing symptoms subscale.
Severity of depression was assessed with the Clinical Global Impression-Severity
scale (CGI-S) [55]. The questionnaire assesses the clinical status of the adolescent, rated
by the therapist, on a 7-point scale from ‘normal, no depressive symptoms to ‘most severe
depressive symptoms’.
Global functioning of the adolescent was assessed with the therapist-rated Children
Global Assessment Scale (CGAS) [56,57]. The ratings of the measure are based on a
0–100 point scale providing an overall estimation of current functioning, taking all avail-
able information into account. More impairment in global functioning is represented by
lower scores.
2.9. Missing Data
An intention-to-treat design was applied and multiple imputation was used to handle
the missing data [58] in data measured with questionnaires. The proportions of missing
data is presented in Figure 1. Missing data from the clinical interview K-SADS was not
imputed. Ten datasets were constructed using the R [59] package Mice [60] (25 iterations)
by predictive mean matching. Statistical analyses were performed on each imputed dataset
and subsequently pooled using Rubin’s rules [58]. Imputation performance was assessed
by comparing the pooled results from analyses performed on the imputed datasets to
those performed on the non-imputed data. Sensitivity analyses were conducted to test the
robustness of the findings.
2.10. Statistical Analysis
Between-group differences in baseline demographic, clinical diagnoses, and clinical
characteristics were analyzed using t-tests and Mann-Whitney tests for continuous variables
and chi-square tests for categorical variables. Odds ratios (OR) for drop-out between
participants in the blended CBT and face-to-face CBT condition and between the blended
CBT and treatment as usual condition were calculated.
Differences in the primary outcome remission between treatment conditions blended
CBT and face-to-face CBT and between blended CBT and TAU were analyzed separately
for post-intervention and six-month follow-up, with binomial logistic regression models
controlling for age and gender.
To examine secondary outcomes, we analyzed between-group differences in depres-
sive symptoms at post-intervention and at six-month follow-up. Due to non-normal
distribution, we used Mann-Whitney tests. We calculated between- and within-group
effect sizes (Cohen’s d) and their 95% confidence intervals. Next, linear mixed models were
constructed using the R package [61] for depressive symptoms, with a random intercept
for each participant, while controlling for age and gender. Interaction terms between con-
dition and dummy timepoints (coded binary) were included to test for differences between
conditions over time [62]. Mixed models control was used for possible non-independence
of the data because of nesting of repeated measurement within individuals, and to deliver
unbiased standard errors of the parameter estimates [63]. Additionally, we calculated the
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participants’ Reliable Change Index (RCI) by dividing the baseline to follow-up differ-
ence in depressive symptoms by the standard error of this difference. RCIs larger than
−1.96 SDs are qualified as no improvement in symptoms and RCI’s smaller than −1.96 SDs
as significant improvement [64]. To test for differences in rates of improvement between
groups, binomial logistic regression models controlling for age and gender were fitted with
improved RCI as dependent variable.
Next, we analyzed between-group differences in suicide risk, internalizing symptoms,
externalizing symptoms, severity of depression and global functioning. Due to non-normal
distribution, we used Mann-Whitney tests. Lastly, the same models were fitted as for
depressive symptoms as outcome, albeit with suicide risk, internalizing symptoms, exter-
nalizing symptoms, severity of depression and global functioning as dependent variable.
3. Results
3.1. Demographics, Clinical Diagnoses and Clinical Characteristics at Baseline
Participants in the blended CBT did not differ significantly from the participants in the
face-to-face CBT or treatment as usual (TAU) condition, respectively, on any of the demographic
characteristics age (t = 0.41, p = 0.68; t = 0.79, p = 0.43), gender (χ2 (1, n = 85) = 0.42, p = 0.52; χ2
(1, n = 85) = 0.19, p = 0.66), education (χ2 (2, n = 62) = 2.33, p = 0.31; χ2 (2, n = 69) = 1.29, p = 0.52),
or ethnicity (χ2 (1, n = 70) = 0.19, p = 0.66; χ2 (1, n = 73) = 0.03, p = 0.86).
The presence of clinical diagnoses did not differ between the blended CBT condition
and the face-to-face CBT condition or between the blended CBT condition and the TAU
condition, with an exception of the presence of social phobia being significantly lower in
the blended CBT condition. An overview of the clinical diagnosis is presented in Table 1.












Face-to-Face CBT Blended CBT vs. TAU




37 (100%) 44 (100%) 40 (100%) * *
Bipolar disorder 0 0 0 * *
Psychotic disorder 0 2 (4.5%) 0 1.72 0.19 *
Panic disorder 1 (2.7%) 4 (9.1%) 1 (2.5%) 1.42 0.23 0.003 0.96
Social phobia 1 (2.7%) 13 (29.5%) 8 (20.0%) 10.13 0.001 5.57 0.02
Specific phobia 1 (2.7%) 4 (9.1%) 3 (7.5%) 1.42 0.23 0.90 0.34
Separation anxiety 1 (2.7%) 2 (4.5%) 2 (5.0%) 1.91 0.66 0.27 0.60
Generalized Anxiety
Disorder 12 (32.4%) 14 (31.8%) 9 (22.5%) 0.003 0.95 0.96 0.33
Post-Traumatic Stress
Disorder (PTSD) 1 (2.7%) 3 (6.8%) 3 (7.5%) 0.73 0.39 0.90 0.34
Acute Stress Disorder 0 0 1 (2.5%) * 0.94 0.33
Obsessive Compulsive
Disorder (OCD) 0 0 0 * *
Anorexia Nervosa 0 1 (2.3%) 0 0.85 0.36 *




5 (13.5%) 6 (13.6%) 5 (12.5%) 0 0.99 0.02 0.90
Conduct Disorder 0 0 0 * *
Oppositional Defiant
Disorder (ODD) 0 1 (2.3%) 1 (2.5%) 0.85 0.36 0.94 0.33
Tic disorder 1 (2.7%) 0 0 1.20 0.27 1.10 0.30
Note. * χ2 was not calculated due to constant values. Missing data from the clinical interviews was not imputed.
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Further, no differences were found in other clinical characteristics, i.e., depressive
symptoms, suicide risk, internalizing symptoms, externalizing symptoms, severity of
depression, or global functioning, between participants in the blended CBT and face-to-
face CBT or TAU condition. Means and between-group differences are presented in Table 2.
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(14.23) 337.0 0.74 −0.09 (−0.52, 0.33) 381.0 0.47 −0.20 (−0.63, 0.23)
3.2. Drop-Out
In total, 58 participants of the 129 (45.0%) dropped out of treatment during the study.
In the blended CBT condition, 15 (36.6%) participants dropped out before the planned
duration of 15 to 20 weeks of treatment, seven because they ended treatment (i.e., four due
to decreased severity of depression and two due to lack of motivation) and eight because
they needed more intensive treatment (i.e., they received additional medication for PTSD
or anxiety or were clinically admitted after a suicide attempt). In the face-to-face CBT
condition, 24 (54.5%) participants dropped out; ten because they discontinued treatment
(i.e., four due to decreased severity of depression and six due to lack of motivation or no
confidence in treatment), ten because they received more intensive treatment (i.e., they
received additional EMDR, emotion regulation therapy or medication or were admitted
after a suicide attempt), and four did not start treatment at all. Participants receiving
blended CBT and participants receiving face-to-face CBT were evenly likely to drop out
(OR = 0.48, 95% CI (0.20, 1.15)). In the treatment as usual condition, 19 (43.2%) dropped out
of treatment, eleven because they ended treatment themselves (i.e., six due to decreased
severity of depression and five due to lack of motivation), six because treatment was
intensified (i.e., they were transferred to forensic care or were admitted because of increased
suicide risk), and two did not start treatment at all. Participants receiving blended CBT
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and participants receiving treatment as usual did not differ in the likelihood to drop out
(OR = 0.76, 95% CI (0.32, 1.81)).
3.3. Adverse Events
During the intervention and follow-up period, overall five serious adverse events
occurred. In the blended CBT condition, two participants attempted suicide during the
intervention. They were referred for more intensive treatment and dropped out of the study.
In the face-to-face CBT condition also, two participants attempted suicide, one during the
intervention and one after ending the intervention. They also dropped out of the study and
received more intensive treatment. A third participant in the face-to-face CBT condition
died by suicide between the six- and 12-month follow-up measurement. In the treatment
as usual condition, no serious adverse events occurred. Participants receiving blended CBT
and participants receiving face-to-face CBT were evenly likely to experience an adverse
event (OR = 0.70, 95% CI (0.11, 4.42)). Odds ratio for adverse between participants receiving
blended CBT and participants receiving treatment as usual could not be calculated due to
a value of 0 in the TAU condition.
3.4. Treatment Dosage
The treatment dosage specifically for the adolescents who completed their blended
treatment consisted of an average of 5.77 (SD = 3.22; range 0–12) sessions. Additionally, they
processed 57.6% (range = 0–98.7%) of the online content. In the face-to-face CBT condition,
adolescents received 15.06 (SD = 4.05; range 6–27) sessions on average. Adolescents who
completed treatment in treatment as usual condition received on average 15.00 (SD = 3.74;
range = 4–20) sessions.
3.4.1. Primary Outcome
Remission
Before start of the treatment, all participants (blended CBT n = 37; face-to-face CBT
n = 44; treatment as usual n = 40) met the criteria for a depressive disorder (i.e., MDD
or Dysthymic Disorder). Data from eight participants on the diagnostic criteria before
treatment was missing; however, they were diagnosed with MDD in the diagnostic process.
At post-intervention, 47 of the 77 participants (61.0%) were in remission from a
depressive disorder. Participants who received blended CBT (n = 12, 54.5%) were evenly
likely to be in remission from the diagnostic criteria of a depressive disorder compared
to participants who received face-to-face CBT (n = 17, 68.0%) (OR = 0.59, 95% CI (0.17,
2.02)). Compared to participants receiving TAU (n = 18, 60.0%), participants receiving
blended CBT were also evenly likely to be in remission (OR = 0.96, 95% CI (0.31, 3.02)).
This indicates no association between remission and treatment condition at post-treatment.
At six-month follow-up, 42 of the 53 participants (79.2%) were in remission. Par-
ticipants in the blended CBT condition (n = 10, 71.4%), compared to participants in the
face-to-face CBT condition (n = 17, 85.0%) (OR = 0.48, 95% CI (0.07, 2.82)) and compared
to participants in the TAU condition (n = 15, 78.9%) (OR = 0.91, 95% CI (0.16, 5.11), were
evenly likely to be in remission.
3.4.2. Secondary Outcomes
Depressive Symptoms
The levels of depressive symptoms at post-intervention and six-months follow-up
did not differ between the blended CBT condition and the face-to-face CBT condition,
nor between the blended CBT condition and the TAU condition. Between-group effect
sizes between blended CBT and face-to-face CBT and blended CBT and TAU showed no
difference in effect (Table 2).
Within-group effect size for blended CBT at post-intervention was moderate (d = 0.81,
95% CI (0.36, 1.26); cf. face-to-face CBT d = 0.86, 95% CI (0.42, 1.30); TAU d = 0.57, 95% CI
(0.15, 1.00)). At the six-month follow-up, within-group effect size for blended CBT was
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large (d = 1.11, 95% CI (0.64, 1.57); cf. face-to-face CBT (d = 0.92, 95% CI (0.48, 1.36); TAU
d = 1.14, 95% CI (0.69, 1.59)).
Change in Depressive Symptoms over Time
Findings showed a significant effect of time on depressive symptoms at post-intervention
(B = −6.97, SE = 1.49, p < 0.001). The estimated decline in depressive symptoms in the blended
CBT at post-intervention condition was not significantly different from the face-to-face CBT
condition (B = 2.62, SE = 1.93, p = 0.17). The estimated decline in depressive symptoms in the
blended CBT condition was also not significantly different compared to the TAU condition
(B = −0.58, SE = 1.92, p = 0.76).
For the six-month follow-up, again time had a significant effect on depressive symp-
toms (B = −11.4, SE = 1.52, p < 0.001). The estimated depressive symptoms showed no
significantly different decrease in the blended CBT condition compared to the decrease
in the face-to-face CBT condition (B = 0.38, SE = 1.95, p = 0.85). The estimated decline in
depressive symptoms comparing blended CBT to TAU was also not significantly different
(B = 1.37, SE = 1.95, p = 0.48).
Reliable Change in Depressive Symptoms
Between baseline and post-intervention, 30.9% of the participants receiving blended
CBT showed a reliable change (i.e., clinically relevant decline) in depressive symptoms,
compared to 42.5% receiving face-to-face CBT and 20.0% receiving TAU. We found that par-
ticipants who received blended CBT were evenly likely to show a clinically relevant decline
in depressive symptoms compared to participants who received face-to-face CBT (OR =1.71,
95% CI (0.56, 5.16)), meaning no association between reliable change and treatment condi-
tion at post-intervention. Compared to participants receiving TAU, participants receiving
blended CBT were also evenly likely to show a clinically relevant decline (OR = 0.52, 95%
CI (0.16, 1.71)).
Between baseline and the six-month follow-up, 46.8% of the participants in the blended
CBT condition showed a clinically relevant decline in depressive symptoms compared to
46.4% in the face-to-face CBT condition (OR = 1.00, 95% CI (0.35, 2.84)) and 40.9% in the
TAU condition (OR = 0.74, 95% CI (0.19, 2.89)), evenly likely to show a reliable change in
symptoms when controlled for gender and age. This means that no association was found
between reliable change and condition at the six-month follow-up. Presented percentages
are based on pooled results from ten imputed datasets.
Other Outcomes
Between-group differences for suicide risk, internalizing symptoms, externalizing
symptoms, severity of symptoms, and global functioning at post-intervention were not
significantly different between blended CBT and face-to-face CBT, nor between blended
CBT and TAU, as presented in Table 2. At the six-month follow-up, between-group
differences between blended CBT and face-to-face CBT, and between blended CBT and TAU
on suicide risk, internalizing symptoms, and externalizing symptoms were not significantly
different (Table 2).
Findings showed a significant effect of time on internalizing symptoms, severity of
symptoms, and global functioning at post-intervention, and no effect on suicide risk and
externalizing symptoms. The estimations showed no significantly different decrease in
the blended CBT condition compared to the decrease in the face-to-face CBT condition,
nor in the blended CBT condition compared to the TAU condition (Table 3). We found
a significant effect of time on suicide risk, internalizing symptoms, and externalizing
symptoms at six-month follow-up. The estimations showed no significant differences in
decrease between blended CBT and face-to-face CBT, nor between blended CBT and TAU.
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Table 3. Linear mixed model results of interaction terms between condition and time, on suicide risk, internalizing
symptoms, externalizing symptoms, severity of depression and global functioning.
Blended CBT vs. Face-to-Face CBT Blended CBT vs. TAU
B SE p B SE p
Suicide risk T3 0.68 0.66 0.30 −0.01 0.66 0.97
Suicide risk T4 0.05 0.65 0.94 0.69 0.66 0.29
Internalizing symptoms T3 2.07 2.26 0.36 0.44 2.27 0.85
Internalizing symptoms T4 1.98 2.24 0.38 0.39 2.27 0.86
Externalizing symptoms T3 −0.94 1.57 0.55 −0.21 1.56 0.89
Externalizing symptoms T4 0.26 1.56 0.87 −0.35 1.57 0.82
Severity of depression T3 0.19 0.29 0.52 0.32 0.30 0.28
Global functioning T3 −1.91 2.60 0.46 −3.69 2.58 0.15
Note. All results originate from separate multivariate regression analyses, from which the independent variable of interest is here reported.
Sensitivity Analyses
Completer-only analyses for individual change over time in depressive symptoms,
suicide risk, internalizing symptoms, externalizing symptoms, severity of depression,
and global functioning showed no differences with the intention-to-treat analyses, with
one exception. Completer-only analyses showed that the estimated decline in depressive
symptoms at post-intervention was smaller in the blended CBT condition compared to the
face-to-face CBT condition (B = 4.79, SE = 2.39, p = 0.045), with a p-value just below the
threshold of 0.05.
4. Discussion
In the present study, a pragmatic quasi-experimental controlled trial was conducted
to evaluate the outcomes of blended CBT. The main aim was to evaluate and compare the
remission rate of depressive disorders between blended CBT and face-to-face CBT and
between blended CBT and treatment as usual in adolescents with clinical depression within
routine care. The second aim was to explore the differences between blended CBT and
face-to-face CBT and between blended CBT and treatment as usual on secondary outcomes
depressive symptoms, suicide risk, internalizing and externalizing symptoms, severity of
depression, and global functioning.
In total, 71 adolescents of the 129 (55.0%) finished treatment according to their treat-
ment protocol, which means 45.0% dropped out. Adolescents receiving blended CBT
did not differ in likelihood to drop out from adolescents receiving face-to-face CBT or
treatment as usual. The drop-out rate was high, albeit comparable to other studies on the
effectiveness of depression treatments (i.e., 50%) [65]. Nevertheless, drop-out in general is
a major problem in mental health care and we need to look for possible ways to increase
the number of patients who finish their treatment. Overall, five adolescents experienced a
serious adverse event, but again with no difference in likelihood between blended CBT
and face-to-face CBT or treatment as usual. Therapists worry that in blended treatment it
is too difficult to identify changes in symptom severity and suicidality [66] and, obviously,
therapists want certainty about this. Our findings revealed a small number of adverse
events, but more importantly, these were not different from treatments consisting of only
face-to-face sessions.
Findings showed that 61.0% of the adolescents at post-intervention and 79.2% of the
adolescents at the six-month follow-up were in remission from a depressive disorder. In line
with our hypotheses, findings showed no difference in likelihood to be in remission between
blended CBT and face-to-face CBT. In contrast to our hypotheses, findings also showed no
difference in likelihood to be in remission between adolescents who received blended CBT
and adolescents who received treatment as usual. All three treatment conditions resulted
in a significant decrease in depressive symptoms with a large effect size. No difference
was found between blended CBT and face-to-face CBT, nor between blended CBT and
treatment as usual in decrease in depressive symptoms, suicide risk, internalizing and
Int. J. Environ. Res. Public Health 2021, 18, 3102 12 of 17
externalizing symptoms, severity of depression and global functioning. Summarizing,
outcomes of blended were not found to be different from to face-to-face CBT and TAU in
treating adolescents with a clinical depression within routine mental health care.
We expected that the remission rate of depressive disorders in blended treatment
would be higher compared to treatment as usual, but our findings showed no difference
in outcome. Our hypothesis, at the start of the study, was based on scarce research on
blended treatment. In recent years, a small, but rising number of studies have examined
the effectiveness of blended CBT in treating adolescents with a depressive disorder and
presented findings comparable to our results. Kobak et al. [33] showed no difference in
decrease of depressive symptoms between adolescents receiving blended CBT or treatment
as usual. It is also known that blended CBT was significantly more effective in reducing
depressive symptoms in adolescents than minimal attention control conditions [34,35].
Despite our findings not being in line with our hypothesis, they are similar to other
recent findings.
We also found, in line with our hypothesis, no difference in likelihood to be in remis-
sion between blended CBT and face-to-face CBT. Several explanations can be offered to
explain the similar effects of blended CBT to face-to-face CBT and treatment as usual. First,
blended CBT and face-to-face CBT have similar treatment techniques, with the modality of
delivery being different. Similar results were found by Sethi et al. [31,32] where the decrease
in depressive symptoms was equal after receiving blended CBT and standard CBT.
Second, our expectation that treatment as usual would be less effective was based on
a meta-analysis by Weisz et al. [11], which showed that evidence-based psychotherapies
outperformed treatment as usual. However, based on a few individual studies included
in the meta-analysis, the authors also mentioned that the difference in effects between
evidence-based therapies and treatment as usual decreased when delivered under clinical
practice conditions. It needs to be mentioned that the treatment as usual condition also
contained evidence-based treatments such as IPT, anti-depressant medication, and running
therapy. This might explain that no difference was found between the outcomes of the
blended treatment condition and the treatment as usual condition.
Third, one of the aspects contributing to treatment outcomes is therapeutic alliance [67].
An explorative study on the therapeutic relation in adolescents receiving blended treatment
for depression showed that therapist-rated alliance was comparable to alliance in face-to-
face treatment in previous research [68]. This implies that the modality of treatment might
not impact the therapeutic alliance between therapists and patients and that this factor
does not seem to affect blended treatment outcome.
4.1. Strengths and Limitations
An important strength of this study is that we compared effects of three active treat-
ment conditions in treating adolescents with a depressive disorder, as suggested by Cui-
jpers [69]. In addition, we examined the effectiveness of the interventions in adolescents
with clinical depression referred for treatment, meaning that these findings can be gen-
eralized to clinical care [70]. We also need to mention some limitations. First, in the
current design, adolescents were not randomized between conditions. Studying the out-
comes of blended CBT without control condition is not preferred. Therefore, we used
historical control conditions, of which it cannot be ruled out that the samples differed in
baseline characteristics, such as the participants wanting to be included in the blended
treatment and having different expectations of treatment than those participating in the
RCT. However, based on our baseline measurement, we found no differences between
participants in the conditions. Second, the sample size of the study is rather small. We
included 129 participants while 210 were required, based on the estimated power. This
might have contributed to the difference in findings from the intention-to-treat analysis
and completers-only analysis of the decrease in depressive symptoms at post-intervention.
Importantly, because the completers-only analysis showed a just significant difference, and
all other completer-only analyses confirmed the findings of the intention-to-treat analyses,
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we interpret that this specific finding was influenced by the small sample size. Third, the
drop-out rate of participants was high, namely 45.0%, although comparable to other studies
on the effectiveness of depression treatments (i.e., 50%) [65]. This resulted in a loss of power.
Fourth, our sample is a relatively highly educated and ethnically homogeneous sample,
which is often the case in study samples [71]. Besides the sample being highly educated
and ethnically homogeneous, patients with acute suicidal thoughts and behavior were
excluded because of safety issues, resulting a part of the patients referred to clinical care
being excluded. Therefore, these findings have a limitation in generalization to adolescents
in regular care.
4.2. Clinical Implications
A previous review demonstrated that the use of blended treatment for adolescents
with a depressive disorder largely depends on acceptance by therapists as well as by pa-
tients [36]. It is likely that this acceptance increases with more insight into the effectiveness
and risks of blended CBT. The current study found no difference in outcomes between
blended CBT, face-to-face CBT and treatment as usual, and, with this, we contribute to the
knowledge on outcomes of blended treatment. Moreover, we could not establish a differ-
ence between the number of adolescents who dropped out from treatment. This means
that, on average, adolescents will benefit from blended CBT as much as from face-to-face
interventions.
Another important unknown is whether blended treatment, i.e., seeing patients face-
to-face much less often, increases the risk of adverse events. Therapists worry that it
may be too difficult to identify changes in symptom severity and suicidality [66] and,
obviously, therapists want certainty about this. Our findings demonstrated a small number
of adverse events, but no difference between treatment conditions. This means that the
worry of therapists about the safety of their patients is legitimate, but, based on our
findings, blended CBT can be a useful addition to effective treatment for adolescents with a
depressive disorder, without increasing the risk of an unseen growing symptom severity of
suicidal ideation. Nonetheless, it goes without saying that further research is imperative.
4.3. Future Research
This study showed that no difference could be observed between blended CBT, face-to-
face CBT and treatment as usual in remission rate and in decrease of depressive symptoms.
On average, they are effective in treating adolescents with a depressive disorder. Nonethe-
less, we also found that not all adolescents showed benefit from the current treatments.
An important future step in research is to study which individuals benefits from which
intervention; that is, gaining more understanding in the use of prognostic and prescriptive
variables or characteristics to determine which treatment works best for whom. The use of
predictive information to support treatment selection, i.e., personalizing treatment, might
improve the individual effectiveness of therapy.
Further, the absence of knowledge on cost-effectiveness of treatment for adolescents
with a depressive disorder is a big gap in the research. It is often suggested that blended
treatment could reduce costs compared to face-to-face treatment; however, there are no
studies to confirm this yet. A previous study showed that therapists experienced an
increase in workload with blended care [66], but it has never been studied in the context of
effectiveness and costs.
5. Conclusions
The present study showed no differences in effects between blended CBT, face-to-face
CBT and treatment as usual: all three treatment conditions resulted in fewer diagnoses of
depressive disorder and showed a significant decrease in depressive symptoms. Further,
we recommend that we should look beyond the mean effects of the interventions and study
whether certain individuals would profit more from one of the interventions than from
the others. The ability to identify patients who can benefit from targeted therapies might
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increase the response to treatment. These results might lead to lowering the threshold for
using blended treatment for adolescents with a depressive disorder and might lead to the
next, and much needed, steps in precision psychiatry.
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